Baidu
map

OCC 2016:汇聚贤才、开创新貌 ——复旦大学生物医学研究院全球公开招募PI

2016-05-30 MedSci MedSci原创

2016年5月27日上午11:30,复旦大学生物医学研究院全球公开招募PI新闻发布会在上海世博中心4楼新闻中心举行,生物医学研究院院长葛均波院士、中国工程院院士韩雅玲、生物医学研究院常务副院长杨芃原教授及生物医学研究院副院长陈震等出席新闻发布会。参加发布会的各家媒体均表示对此次生物医学研究院的全球公开招募计划高度关注;符合招募条件的国内外学者也积极参会,希望通过生物医学研究院的优秀平台实现自己的职

2016年5月27日上午11:30,复旦大学生物医学研究院全球公开招募PI新闻发布会在上海世博中心4楼新闻中心举行,生物医学研究院院长葛均波院士、中国工程院院士韩雅玲、生物医学研究院常务副院长杨芃原教授及生物医学研究院副院长陈震等出席新闻发布会。参加发布会的各家媒体均表示对此次生物医学研究院的全球公开招募计划高度关注;符合招募条件的国内外学者也积极参会,希望通过生物医学研究院的优秀平台实现自己的职业理想和远大抱负。

继往开来,拓展学术建设新视野

复旦大学生物医学研究院成立12年来,在科研成果、人才培养、队伍建设和成果转化等多方面实现了跨越式发展,确保已有的交叉学科和三个研究方向做实做强,努力拓展转化医学和精准医学研究,形成新的交叉学科生长点和下游技术。生物医学研究院成立至今,共发表SCI收录论文约1400篇,其中影响因子大于10的论文共计111篇,大于20的论文共计22篇。在学术建设的同时,研究院进一步建设生物医学技术支撑平台,目前,研究院建立的部分技术子平台已达到国内一流、国际领先的服务水平,以乙酰化为主的功能蛋白质组学翻译后修饰技术已达到世界一流水平。

2016年4月,复旦大学生物医学研究院任命葛均波院士为新任院长。在受聘仪式上,葛均波院士宣布成立复旦大学泛血管医学研究院。复旦大学泛血管医学研究院的成立是在继承生物医学研究院原有学科发展建设传统的同时,又形成的新的交叉学科增长点。为实现生物医学研究院在2020年前跻身世界一流生物医学交叉研究机构行列的目标,人才战略将是核心问题。基于此,生物医学研究院正式推进引进人才招募计划,计划面向全球招募40名高层次科研工作者。通过多层次、多渠道、高水准的人才招募促进生物医学研究院的发展和壮大,同时以此为契机向外界传递生物医学研究院的价值观—以生物医学发展为使命而不断激励斗志,为中国生物医学行业站在世界至高点而奋发图强。


葛均波院士授发韩雅玲院士复旦大学泛血管医学研究院顾问委员会委员聘书

汇聚贤才,开创科研发展新局面

复旦大学生物医学研究院全球公开招募PI新闻发布会现场循环播放了生物医学研究院纪录片,用具体的声音和画面向社会传递着生物医学研究院的发展理念,专题片展示了一个踏实、奋进、自信而又充满科学理想的生物医学研究院,多年来,生物医学研究院一步一个脚印坚定向前发展,积极进取、锐意创新。在未来,生物医学研究院将继续与时俱进,大力发展交叉学科、开创新的研究领域,继续引领行业趋势。

在发布会上,生物医学研究院院长葛均波院士致辞并阐述了生物医学研究院未来愿景和人才战略,他认为,生物医学研究院经过多年的发展已经形成了极具优势的平台,无论是技术方面还是资金方面,都能够充分保障高层次人才的实际需要,而对科学和人才的充分尊重,则体现了生物医学研究院浓厚的人文气质,受聘人才可以得到更好、更多在国际舞台展示研究成果的机会。本次PI招募还特别强调激励交叉型科研人才的加入,这符合国际主流生物医学研究的发展趋势!

随后,生物医学研究院常务副院长杨芃原教授公布了此次全球PI招聘计划与相关条件:生物医学研究院实行首席科学家(PI)负责制,采用灵活方式与各院系和附属医院进行共建。此次招聘的方向有:表观遗传学、分子细胞生物学、生物信息学和大数据分析、蛋白质组学、结构生物学(重点关注冷冻电镜方向)、活性小分子药物筛选、转化医学技术(癌症、心血管、出生缺陷和干细胞)等。招聘类型分为青年PI和杰出PI两部分,分别对应年龄不超过40周岁和55周岁的高层次人才,杨芃原教授对PI招聘的薪金以及启动资金也有明确的说明。

在谈及生物医学研究院招聘的宣传模式时,杨芃原教授提到,此次PI招募将通过多渠道进行全球范围招募—不仅通过电视、报纸等传统媒体开展招募宣传,还会通过官方网站、微信公众号、微博、Facebook、Twitter等新媒体进行信息发布。在后期还将进行媒体整合宣传,即深入打造电视、纸媒、新媒体三位一体的传播方式,实现持续、有效的传播效果。

在记者群访环节,参加此次招募发布会的记者纷纷针对此次发布会的招募细节提出问题,如本次生物医学研究院PI招募的亮点、生物医学研究院是如何进行人才培养以及将青年人才不断补充到科研团队中、国外教授能否在不关闭国外实验室的情况下同时开展国内实验室的创建工作……生物医学研究院院长葛均波院士和常务副院长杨芃原教授对这些问题进行了详细回答。

此次招募展现了生物医学研究院坚实的平台底蕴和加大人才引进力度的决心,研究院希望通过此次人才招募吸引高层次人才、推动自身硬实力和软实力的共同发展。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1910066, encodeId=13e419100661a, content=<a href='/topic/show?id=21574368886' target=_blank style='color:#2F92EE;'>#大学生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43688, encryptionId=21574368886, topicName=大学生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Sun Oct 09 08:14:00 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285263, encodeId=197f128526383, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353032, encodeId=a629135303261, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461458, encodeId=e8e3146145884, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538471, encodeId=2d1715384e14e, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543613, encodeId=f26d154361346, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548501, encodeId=0d82154850147, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1910066, encodeId=13e419100661a, content=<a href='/topic/show?id=21574368886' target=_blank style='color:#2F92EE;'>#大学生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43688, encryptionId=21574368886, topicName=大学生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Sun Oct 09 08:14:00 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285263, encodeId=197f128526383, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353032, encodeId=a629135303261, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461458, encodeId=e8e3146145884, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538471, encodeId=2d1715384e14e, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543613, encodeId=f26d154361346, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548501, encodeId=0d82154850147, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1910066, encodeId=13e419100661a, content=<a href='/topic/show?id=21574368886' target=_blank style='color:#2F92EE;'>#大学生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43688, encryptionId=21574368886, topicName=大学生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Sun Oct 09 08:14:00 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285263, encodeId=197f128526383, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353032, encodeId=a629135303261, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461458, encodeId=e8e3146145884, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538471, encodeId=2d1715384e14e, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543613, encodeId=f26d154361346, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548501, encodeId=0d82154850147, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2016-06-01 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=1910066, encodeId=13e419100661a, content=<a href='/topic/show?id=21574368886' target=_blank style='color:#2F92EE;'>#大学生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43688, encryptionId=21574368886, topicName=大学生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Sun Oct 09 08:14:00 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285263, encodeId=197f128526383, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353032, encodeId=a629135303261, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461458, encodeId=e8e3146145884, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538471, encodeId=2d1715384e14e, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543613, encodeId=f26d154361346, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548501, encodeId=0d82154850147, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1910066, encodeId=13e419100661a, content=<a href='/topic/show?id=21574368886' target=_blank style='color:#2F92EE;'>#大学生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43688, encryptionId=21574368886, topicName=大学生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Sun Oct 09 08:14:00 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285263, encodeId=197f128526383, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353032, encodeId=a629135303261, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461458, encodeId=e8e3146145884, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538471, encodeId=2d1715384e14e, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543613, encodeId=f26d154361346, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548501, encodeId=0d82154850147, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2016-06-01 saikp
  6. [GetPortalCommentsPageByObjectIdResponse(id=1910066, encodeId=13e419100661a, content=<a href='/topic/show?id=21574368886' target=_blank style='color:#2F92EE;'>#大学生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43688, encryptionId=21574368886, topicName=大学生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Sun Oct 09 08:14:00 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285263, encodeId=197f128526383, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353032, encodeId=a629135303261, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461458, encodeId=e8e3146145884, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538471, encodeId=2d1715384e14e, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543613, encodeId=f26d154361346, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548501, encodeId=0d82154850147, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1910066, encodeId=13e419100661a, content=<a href='/topic/show?id=21574368886' target=_blank style='color:#2F92EE;'>#大学生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43688, encryptionId=21574368886, topicName=大学生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Sun Oct 09 08:14:00 CST 2016, time=2016-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285263, encodeId=197f128526383, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353032, encodeId=a629135303261, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461458, encodeId=e8e3146145884, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538471, encodeId=2d1715384e14e, content=<a href='/topic/show?id=751e42660f1' target=_blank style='color:#2F92EE;'>#复旦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42660, encryptionId=751e42660f1, topicName=复旦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c312994908, createdName=saikp, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543613, encodeId=f26d154361346, content=<a href='/topic/show?id=509b3418366' target=_blank style='color:#2F92EE;'>#医学研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34183, encryptionId=509b3418366, topicName=医学研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b713593170, createdName=ms1065684921169360, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548501, encodeId=0d82154850147, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Wed Jun 01 00:14:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]

相关资讯

科技部:生物医学重点专项背后“66位专家”名单揭晓!

自2月16日以来,科技部先后发布了四批、34个重点专项2016年度项目申报指南;其中与生物医学相关的专项共有6个,包括“蛋白质机器与生命过程调控”重点专项、“重大科学仪器设备开发”重点专项、“精准医学研究”重点专项、“生殖健康及重大出生缺陷防控研究”重点专项、“生物医用材料研发与组织器官修复替代”重点专项以及“生物安全关键技术研发”重点专项。 科技部《通知》明确了项目组织申报要求及评审流程

科技部:2014年973计划验收结果(生物医学领域)

近日,科技部按照《国家重点基础研究发展计划(973计划)管理办法》和《国家重点基础研究发展计划专项经费管理办法》有关规定,完成了973计划(含重大科学研究计划)2010年立项137个项目、2012年立项2个项目和2013年立项2个项目的结题验收。现将项目验收结果通知如下: 1.“主要农作物核心种质重要农艺性状单元型区段及互作研究”等141个项目自立项实施以来,总体执行情况较好,达到了预期目

Nature:进化路上,再生能力消失了……

一个来自柏林für Naturkunde博物馆的古生物学家团队以及布朗大学对两栖类动物化石的合作研究认为现代火蜥蜴的强大再生功能源于其四足脊椎动物祖先,而在漫长的进化中这一特异功能却逐渐地消失了。 火蜥蜴是四足脊椎动物中的佼佼者,它们天然拥有强大的再生能力。在一生中,它们的外肢、尾巴、以及内在器官等在损伤之后都能通过再生恢复。它们的这一特性内在的机制一直以来也是科学家们十分感兴趣的问题,希

博物馆奇妙夜——生物、医学篇

世界各国都有各种形式的生物、医学博物馆,中国当然也不例外,也有许多生物、医学博物馆,里面别有洞天,平时整日泡在实验室的你,是不是也该考虑应个景,换个阵地继续接受专业知识的熏陶?不如就随谷君去逛逛生物、医药博物馆吧!

2015年度“***”建议人选开始公示啦!(生物医学类21人)

<p align="center"><a href="http://www.bioon.com/trends/UploadFiles/201601/20160112213554575.png" target="_blank" rel="noopener"><img /></a></p> <p>关于对2015年度&ldquo;***奖励计划&rdquo;建议人选进行公示的通知</p> <p>根据《&ldquo;***奖励计划&rdquo;实施办法》,经高校推荐、通讯评审、<a class="channel_keylink" href="//www.sandwebs.com/meeting/">会议</a>评审等程序,共产生418名2015年度***特聘教授、讲座教授和青年学者建议人选。现将名单予以公示,公示期自201

盘点2015年生物医学大事件

每年年底,一定会有许多总结。科学研究也一样,过去《自然》和《科学》已经许多研究机构都会有这类总结。能准确把握学术热点,本身就是科学鉴赏力的表现。我自认为鉴赏力有限,但毕竟是这个圈子内的,这里先尝试一下,作为抛砖引玉。希望大家能批评补充。一、中国女科学家屠呦呦获得诺贝尔生理学或医学奖。这是中国科学家首次在中国本土研究获得的诺贝尔科学类奖,具有重要的里程碑意义。从次以后,中国彻底摘掉诺贝尔科学家零的帽

Baidu
map
Baidu
map
Baidu
map